Health Care and Biotech

Alcidion’s IT Targets Hospital Efficiency

Alcidion is an emerging operator in the field of hospital IT, with technology that can reduce deaths attributable to medical error. The stock price has doubled since it listed on ASX in February this year.

Dec 19 2016

Estia Health Beset By Uncertainty

Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.

Dec 13 2016


Rebound For Sirtex

Michael Gable of Fairmont Equities suggests technically, Sirtex Medical should be set to recover.

Dec 13 2016

Sirtex Reaction Overdone

Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.

Dec 12 2016


Previous Stories

Can ResMed Continue To Deliver?

Jan 29 2013

ResMed’s result was well received by brokers as it beat forecasts, but just how much more upside can be expected?


Healthcare Is Expensive, May Be Time For Profits

Jan 23 2013

The healthcare sector is strong and many stocks are fully priced. Investors need to assess individual stocks rather than take a broad view, according to several brokers.


Weekly Broker Wrap: Slowly, Slowly Grinds The Recovery

Jan 21 2013

Rallies will be hard fought this year and stock picking needs to be selective, as brokers air expectations for resources, retail, building, software and healthcare.


Australian Stocks: What Happened Today?

Dec 21 2012

A wrap of the day’s activity on the Australian stock market.


Australian Stocks: What Happened Today?

Dec 20 2012

A wrap of the day’s activity on the Australian stock market.


Australian Stocks: What Happened Today?

Dec 18 2012

A wrap of the day’s activity on the Australian stock market.


To Like Or Not Like Mesoblast?

Dec 14 2012

While brokers agree there is huge potential upside in the company’s stem cell products, opinions are mixed about the near term prospects for commercialisation.


Starpharma Sparkles With Dendrimer Promise

Dec 12 2012

Despite a trial setback, Starpharma has some pundits seeing good value in multiple applications of its Dendrimer technology.


Australian Stocks: What Happened Today?

Dec 07 2012

A wrap of the day’s activity on the Australian stock market.


Australian Stocks: What Happened Today?

Dec 03 2012

A wrap of the day’s activity on the Australian stock market.



Analyse The Market From A Different Angle